help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MARKOWICZ, P.
Right arrow Articles by the ARDS Study Group,
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MARKOWICZ, P.
Right arrow Articles by the ARDS Study Group,

Am. J. Respir. Crit. Care Med., Volume 161, Number 6, June 2000, 1942-1948

Multicenter Prospective Study of Ventilator-Associated Pneumonia During Acute Respiratory Distress Syndrome
Incidence, Prognosis, and Risk Factors

PHILIPPE MARKOWICZ, MICHEL WOLFF, KAMEL DJEDAÏNI, YVES COHEN, JEAN CHASTRE, CHRISTOPHE DELCLAUX, JACQUES MERRER, BERNARD HERMAN, BENOIT VEBER, ALAIN FONTAINE, DIDIER DREYFUSS, and the ARDS Study Group

We investigated the incidence, risk factors for, and outcome of ventilator-associated pneumonia (VAP) in patients with acute respiratory distress syndrome (ARDS). We compared 134 patients with ARDS with 744 patients without ARDS on mechanical ventilation. Fiberoptic bronchoscopic examination and quantitative bacterial cultures (protected brush or catheter sampling [threshold: 103 cfu/ml], or bronchoalveolar lavage [threshold: 104 cfu/ml]) were used to diagnose pneumonia. VAP occurred in 49 patients (36.5%). The incidence of pneumonia was 23% (173 of 744 patients) among patients without ARDS (p < 0.002). Nonfermenting gram-negative rods caused significantly more pneumonia in ARDS patients. Mortality rates were identical in ARDS patients with (28 of 49 patients, 57%) and without (50 of 85 patients, 59%) pulmonary infection (p = 0.8). VAP resulted in a considerable increase in attributable time on mechanical ventilation of both the overall population of ARDS patients and of survivors. Both the use of sucralfate (adjusted odds ratio [OR]: 4.42; 95% confidence interval [CI]: 2.01 to 9.7, p = 0.0002) and the duration of exposure to sucralfate (adjusted OR: 1.206; 95% CI: 1.095 to 1.328, p = 0.0002) were associated with an increased risk of VAP during ARDS. VAP considerably prolongs the time on mechanical ventilation without affecting survival. Patients given sucralfate may be at greater risk of developing pulmonary infection during ARDS.




This article has been cited by other articles:


Home page
ChestHome page
M. Zambon and J.-L. Vincent
Mortality Rates for Patients With Acute Lung Injury/ARDS Have Decreased Over Time
Chest, May 1, 2008; 133(5): 1120 - 1127.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
S. M. Koenig and J. D. Truwit
Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention
Clin. Microbiol. Rev., October 1, 2006; 19(4): 637 - 657.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
K. A. Davis
Ventilator-associated pneumonia: a review.
J Intensive Care Med, July 1, 2006; 21(4): 211 - 226.
[Abstract] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Reutershan, A. Basit, E. V. Galkina, and K. Ley
Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury
Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L807 - L815.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. T. Bauer, M. Valencia, J. R. Badia, S. Ewig, J. Gonzalez, M. Ferrer, and A. Torres
Respiratory Microbiology Patterns Within the First 24 h of ARDS Diagnosis: Influence on Outcome
Chest, July 1, 2005; 128(1): 273 - 279.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. T. Sadikot, T. S. Blackwell, J. W. Christman, and A. S. Prince
Pathogen-Host Interactions in Pseudomonas aeruginosa Pneumonia
Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1209 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia
Am. J. Respir. Crit. Care Med., February 15, 2005; 171(4): 388 - 416.
[Full Text] [PDF]


Home page
ChestHome page
H. M. Babcock, J. E. Zack, T. Garrison, E. Trovillion, M. Jones, V. J. Fraser, and M. H. Kollef
An Educational Intervention to Reduce Ventilator-Associated Pneumonia in an Integrated Health System: A Comparison of Effects
Chest, June 1, 2004; 125(6): 2224 - 2231.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. Apisarnthanarak, G. Holzmann-Pazgal, A. Hamvas, M. A. Olsen, and V. J. Fraser
Ventilator-Associated Pneumonia in Extremely Preterm Neonates in a Neonatal Intensive Care Unit: Characteristics, Risk Factors, and Outcomes
Pediatrics, December 1, 2003; 112(6): 1283 - 1289.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. E. Ost, C. S. Hall, G. Joseph, C. Ginocchio, S. Condon, E. Kao, M. LaRusso, R. Itzla, and A. M. Fein
Decision Analysis of Antibiotic and Diagnostic Strategies in Ventilator-associated Pneumonia
Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1060 - 1067.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. Dreyfuss, J.-D. Ricard, and G. Saumon
On the Physiologic and Clinical Relevance of Lung-borne Cytokines during Ventilator-induced Lung Injury
Am. J. Respir. Crit. Care Med., June 1, 2003; 167(11): 1467 - 1471.
[Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
P. J. O'Reilly, J. M. Hickman-Davis, I. C. Davis, and S. Matalon
Hyperoxia Impairs Antibacterial Function of Macrophages Through Effects on Actin
Am. J. Respir. Cell Mol. Biol., April 1, 2003; 28(4): 443 - 450.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
I. Goldstein, F. Wallet, A. Nicolas-Robin, F. Ferrari, C.-H. Marquette, and J.-J. Rouby
Lung Deposition and Efficiency of Nebulized Amikacin during Escherichia coli Pneumonia in Ventilated Piglets
Am. J. Respir. Crit. Care Med., November 15, 2002; 166(10): 1375 - 1381.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. Chastre and J.-Y. Fagon
Ventilator-associated Pneumonia
Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 867 - 903.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. E. Olson, B. G. Harmon, and M. H. Kollef
Silver-Coated Endotracheal Tubes Associated With Reduced Bacterial Burden in the Lungs of Mechanically Ventilated Dogs
Chest, March 1, 2002; 121(3): 863 - 870.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Eggimann and D. Pittet
Infection Control in the ICU
Chest, December 1, 2001; 120(6): 2059 - 2093.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. Brun-Buisson and F. Lemaire
Administration of Antibiotics for Pneumonia during Respiratory Failure: Reaching the Target
Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1554 - 1555.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Critical Care Medicine in AJRCCM 2000
Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1347 - 1361.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. RIALP, A. J. BETBESE, M. PEREZ-MARQUEZ, and J. MANCEBO
Short-term Effects of Inhaled Nitric Oxide and Prone Position in Pulmonary and Extrapulmonary Acute Respiratory Distress Syndrome
Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 243 - 249.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2000 American Thoracic Society
  ATS Sleep Tracings Quiz